QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.

被引：0
|
作者：
Gavai, AV [1 ]
Vaz, RJ [1 ]
Santone, K [1 ]
Chandrasena, G [1 ]
Nayeem, A [1 ]
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
354-MEDI
引用
收藏
页码：U66 / U66
页数：1
相关论文
共 50 条
  • [1] A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series
    Vaz, RJ
    Nayeem, A
    Santone, K
    Chandrasena, G
    Gavai, AV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (17) : 3816 - 3820
  • [2] QSAR studies of quinidine inhibition of CYP2D6
    Hutzler, JM
    Wienkers, LC
    DRUG METABOLISM REVIEWS, 2002, 34 : 172 - 172
  • [3] STEREOSELECTIVE INHIBITION OF CYP2D6 BY CHLORPHENIRAMINE
    SALCEDO, JA
    YASUDA, SU
    MURPHY, MP
    WOOSLEY, RL
    FLOCKHART, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 149 - 149
  • [4] Inhibition of CYP2D6 activity by bupropion
    Kotlyar, M
    Brauer, LH
    Tracy, TS
    Hatsukami, DK
    Harris, J
    Bronars, CA
    Adson, DE
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 226 - 229
  • [5] EFFECT OF CHIRAL ISOMERS QUINIDINE AND QUININE ANALOGUES ON CYP2D6 INHIBITION - A QSAR INVESTIGATION
    Ai, Chunzhi
    Hu, Zhuohan
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2008, 40 : 121 - 121
  • [6] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [7] Fuzzy pharmacophore triplets: New descriptors for the construction of QSAR models and application to Cyp2D6 inhibition
    Barbosa, Frederique
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 126 - 126
  • [8] Inhibition of CYP2D6 by antipsychotic drugs.
    Shin, JG
    Soukhova, N
    Desta, Z
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 188 - 188
  • [9] CYP2D6 inhibition in patients treated with sertraline
    Sproule, BA
    Otton, SV
    Cheung, SW
    Zhong, XH
    Romach, MK
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (02) : 102 - 106
  • [10] Dynamics and persistence of CYP2D6 inhibition by paroxetine
    Jurica, J.
    Zourkova, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (04) : 294 - 300
12345